Merck Continues Pursuit Of Cardiovascular Candidates With Theravance Partnership
This article was originally published in The Pink Sheet Daily
Executive Summary
The New Jersey-based big pharma continues to take shots on the cardiovascular goal, even after a string of failures in the space.